Trial intelligence / Profile preview

Alkaline Diet for Insulin Sensitivity

NCT02501343Completed

Sponsor
Garvan Institute of Medical Research
Start
Mar 2015
Primary completion
Dec 2016
Countries
1
01

Overview

Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and dysglycemia (2 arms), sponsored by Garvan Institute of Medical Research. Primary endpoint: Changes in venous blood pH at 3 hours. Started Mar 2015; status: completed.

02

Conditions

type 2 diabetes mellitus (T2DM)dysglycemia

Beyond the preview

Go deeper on NCT02501343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02501343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call